NYSE:CHE
Chemed Corp Stock News
$559.81
-4.53 (-0.80%)
At Close: May 21, 2024
Chemed (CHE) Surges 3.3%: Is This an Indication of Further Gains?
09:20am, Monday, 20'th Jun 2022
Chemed (CHE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Here's Why Investors Should Retain Chemed (CHE) Stock Now
04:20pm, Monday, 13'th Jun 2022 Zacks Investment Research
Strong performance across Chemed's (CHE) Roto-Rooter arm and increased home-based admissions raise investors' confidence.
Here's Why Investors Should Retain Chemed (CHE) Stock Now
01:32pm, Monday, 13'th Jun 2022
Strong performance across Chemed's (CHE) Roto-Rooter arm and increased home-based admissions raise investors' confidence.
Chemed Corporation to Present at the Jefferies 2022 Healthcare Conference
12:00pm, Thursday, 02'nd Jun 2022
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2022 Healthcare Conference on Thursday, June 9, 2022, at approximately
Amedisys (AMED) Down 11% Since Last Earnings Report: Can It Rebound?
05:12pm, Friday, 27'th May 2022 Zacks Investment Research
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dividend Champion, Contender, And Challenger Highlights: Week Of May 22
05:04am, Sunday, 22'nd May 2022 Seeking Alpha
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference
12:00pm, Wednesday, 11'th May 2022
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022, at ap
Chemed's (CHE) Q1 Earnings Top Estimates, Margins Increase
03:01pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
In Q1, Chemed's (CHE) VITAS revenue decline was primarily the result of a 4.1% decline in days of care.
Chemed Corporation (CHE) CEO Kevin McNamara on Q1 2022 Results - Earnings Call Transcript
02:45pm, Wednesday, 27'th Apr 2022
Chemed Corporation (NYSE:CHE ) Q1 2022 Earnings Conference Call April 27, 2022 10:00 AM ET Company Participants Kevin McNamara – President and Chief Executive Officer Nick Westfall – President and
Chemed's (CHE) Q1 Earnings Top Estimates, Margins Increase
12:18pm, Wednesday, 27'th Apr 2022
In Q1, Chemed's (CHE) VITAS revenue decline was primarily the result of a 4.1% decline in days of care.
Chemed (CHE) Q1 Earnings Surpass Estimates
10:15pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Chemed (CHE) delivered earnings and revenue surprises of 6.68% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Hold on to Chemed (CHE) Stock For Now
03:18pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Investors are optimistic about robust performance by Chemed's (CHE) Roto-Rooter arm.
Here's Why You Should Hold on to Chemed (CHE) Stock For Now
12:48pm, Thursday, 07'th Apr 2022
Investors are optimistic about robust performance by Chemed's (CHE) Roto-Rooter arm.
Chemed To Report First-Quarter 2022 Earnings April 26, Related Conference Call To Be Held On April 27
11:43am, Thursday, 07'th Apr 2022
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2022, on Tuesday, April 26, 2022, following the
Dividend Champion, Contender, And Challenger Highlights: Week Of March 13
05:43am, Sunday, 13'th Mar 2022 Seeking Alpha
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
